NASDAQ : AARD
Aardvark Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.36 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.76M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Details
| Name | Aardvark Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 28 |
| Founded | 2017 |
| Ipo Date | 2025-02-13 |
| Ceo | Tien-Li Lee |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US0029421007 |
| Cusip | 002942100 |
| Cik | 1774857 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Bryan Jones Ph.D. | Chief Executive Officer of Ardia |
| Dr. Tien-Li Lee M.D. | Chief Executive Officer, Secretary and Chairman |
| Nelson B. Sun M.B.A. | Chief Financial Officer and Chief Operating Officer |
| Dr. Manasi Sinha Jaiman M.D., M.P.H. | Chief Medical Officer |
| Dr. Dvorit Samid Ph.D. | Executive Vice President of Medical Affairs |
| Dr. Zhenhuan Zheng Ph.D. | Chief Research Officer |
| Ron Lewis II, Ph.D. | Vice President and Head of CMC |
| Justin T. Stege Ph.D. | Vice President and Head of Project Management and Strategy |
| Derrick C. Li | Chief Business Officer |
Contact
| Address | 4370 La Jolla Village Drive, Suite 1050, San Diego, California 92122, United States |
| Phone | 858 225 7696 |
| Website | https://aardvarktherapeutics.com |